Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BALAXI PHARMA vs ENTERO HEALTHCARE SOLUTIONS LTD. - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BALAXI PHARMA ENTERO HEALTHCARE SOLUTIONS LTD. BALAXI PHARMA/
ENTERO HEALTHCARE SOLUTIONS LTD.
 
P/E (TTM) x 12.3 76.0 16.2% View Chart
P/BV x 2.2 3.5 64.0% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 BALAXI PHARMA   ENTERO HEALTHCARE SOLUTIONS LTD.
EQUITY SHARE DATA
    BALAXI PHARMA
Mar-24
ENTERO HEALTHCARE SOLUTIONS LTD.
Mar-24
BALAXI PHARMA/
ENTERO HEALTHCARE SOLUTIONS LTD.
5-Yr Chart
Click to enlarge
High Rs6861,258 54.6%   
Low Rs400974 41.0%   
Sales per share (Unadj.) Rs221.4901.9 24.5%  
Earnings per share (Unadj.) Rs-2.29.2 -23.9%  
Cash flow per share (Unadj.) Rs-0.314.9 -1.8%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs181.3376.2 48.2%  
Shares outstanding (eoy) m10.9043.49 25.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.51.2 198.2%   
Avg P/E ratio x-248.0122.0 -203.3%  
P/CF ratio (eoy) x-2,051.674.9 -2,739.0%  
Price / Book Value ratio x3.03.0 101.0%  
Dividend payout %00-   
Avg Mkt Cap Rs m5,91948,549 12.2%   
No. of employees `000NANA-   
Total wages/salary Rs m2801,511 18.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m2,41339,223 6.2%  
Other income Rs m6144 4.4%   
Total revenues Rs m2,41939,367 6.1%   
Gross profit Rs m621,118 5.6%  
Depreciation Rs m21250 8.4%   
Interest Rs m28657 4.2%   
Profit before tax Rs m20356 5.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m44-42 -103.7%   
Profit after tax Rs m-24398 -6.0%  
Gross profit margin %2.62.9 90.8%  
Effective tax rate %218.5-11.9 -1,830.3%   
Net profit margin %-1.01.0 -97.5%  
BALANCE SHEET DATA
Current assets Rs m2,10220,110 10.5%   
Current liabilities Rs m5426,019 9.0%   
Net working cap to sales %64.635.9 179.9%  
Current ratio x3.93.3 116.1%  
Inventory Days Days82 316.0%  
Debtors Days Days84357 1,471.4%  
Net fixed assets Rs m4823,150 15.3%   
Share capital Rs m109435 25.1%   
"Free" reserves Rs m1,86715,928 11.7%   
Net worth Rs m1,97616,363 12.1%   
Long term debt Rs m0455 0.0%   
Total assets Rs m2,58323,259 11.1%  
Interest coverage x1.71.5 112.2%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.91.7 55.4%   
Return on assets %0.14.5 3.2%  
Return on equity %-1.22.4 -49.7%  
Return on capital %2.46.0 40.2%  
Exports to sales %00-   
Imports to sales %00.1 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA29 0.0%   
Fx inflow Rs m6480-   
Fx outflow Rs m1929 65.6%   
Net fx Rs m629-29 -2,199.5%   
CASH FLOW
From Operations Rs m49-366 -13.3%  
From Investments Rs m-10-7,051 0.1%  
From Financial Activity Rs m3038,629 3.5%  
Net Cashflow Rs m3411,223 27.9%  

Share Holding

Indian Promoters % 66.0 14.4 457.9%  
Foreign collaborators % 0.0 38.0 -  
Indian inst/Mut Fund % 16.5 31.6 52.3%  
FIIs % 16.5 23.8 69.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 34.0 47.6 71.5%  
Shareholders   7,863 36,767 21.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BALAXI PHARMA With:   ADANI ENTERPRISES    REDINGTON    MMTC    SIRCA PAINTS INDIA    UNIPHOS ENT    


More on BALAXI PHARMA vs ENTERO HEALTHCARE SOLUTIONS LTD.

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

BALAXI PHARMA vs ENTERO HEALTHCARE SOLUTIONS LTD. Share Price Performance

Period BALAXI PHARMA ENTERO HEALTHCARE SOLUTIONS LTD. S&P BSE HEALTHCARE
1-Day 5.09% 0.26% 0.60%
1-Month -13.44% -4.48% -0.86%
1-Year -80.75% 13.63% 42.73%
3-Year CAGR -49.63% 4.35% 20.10%
5-Year CAGR -33.73% 2.59% 26.09%

* Compound Annual Growth Rate

Here are more details on the BALAXI PHARMA share price and the ENTERO HEALTHCARE SOLUTIONS LTD. share price.

Moving on to shareholding structures...

The promoters of BALAXI PHARMA hold a 66.0% stake in the company. In case of ENTERO HEALTHCARE SOLUTIONS LTD. the stake stands at 52.4%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of BALAXI PHARMA and the shareholding pattern of ENTERO HEALTHCARE SOLUTIONS LTD..

Finally, a word on dividends...

In the most recent financial year, BALAXI PHARMA paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

ENTERO HEALTHCARE SOLUTIONS LTD. paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of BALAXI PHARMA, and the dividend history of ENTERO HEALTHCARE SOLUTIONS LTD..

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Trades Higher | Nifty Above 23,450 | Info Edge & SJVN Jump 5% Sensex Today Trades Higher | Nifty Above 23,450 | Info Edge & SJVN Jump 5%(10:30 am)

Asian markets traded higher on Friday, following the overnight rally on Wall Street, and the release of economic data in the region.